咨询与建议

看过本文的还看了

相关文献

该作者的其他文献

文献详情 >Primary hepatoid adenocarcinom... 收藏

Primary hepatoid adenocarcinoma of the lung in Yungui Plateau,China:A case report

Primary hepatoid adenocarcinoma of the lung in Yungui Plateau,China:A case report

作     者:Yun-Fei Shi Jia-Gui Lu Qing-Mei Yang Jin Duan You-Ming Lei Wei Zhao Yin-Qiang Liu 

作者机构:Department of Thoracic Surgery in the Elderly the First Affiliated Hospital of Kunming Medical University 

出 版 物:《World Journal of Clinical Cases》 (世界临床病例杂志)

年 卷 期:2019年第7卷第13期

页      面:1711-1716页

核心收录:

学科分类:10[医学] 

基  金:Supported by the Yunnan Health Science and Technology Plan Project Task Book,No.2017NS020 Yunnan Provincial Health and Family Planning Commission Reserve Talent Project,No.H-2017013 Yunnan Provincial Science and Technology Project,No.2017FE467(-142) 2018 CSCOQilu Tumor Project,No.YQ201802-011 the Educational Reform Project of Kunming Medical University,No.2018-JY-Y-046 

主  题:Hepatic adenocarcinoma Lung cancer Immunohistochemistry α-Fetoprotein Case report 

摘      要:BACKGROUND Hepatoid adenocarcinoma(HAC)occurs in extrahepatic organs such as the gastrointestinal tract,testes,ovaries,lungs,mediastinum and pancreas,and frequently produces a-fetoprotein(AFP).HAC of the lung(HAL)is rare,characterized by difficult treatment and poor *** are no reports of HAL in Yunnan-Guizhou Plateau,*** S UMMARY A 60-year-old male patient was clinically diagnosed with HAL pT3 NOM0,stageⅡ*** computed tomography revealed a 7.5 cm x 7.2 cm soft tissue mass located in the right lung upper lobe and the adjacent superior *** upper lobectomy was *** diagnosis of HAL was confirmed by pathological examination,and the patient received paclitaxel and carboplatin as adjuvant chemotherapy after *** USION Clinical manifestations,pathological features,imaging findings,auxiliary examination,and treatment planning of HAL are presented to help clinicians improve their diagnosis and treatment.

读者评论 与其他读者分享你的观点

用户名:未登录
我的评分